Literature DB >> 18355442

Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion.

Yunge Zhao1, Charles E Lyons, Aizhen Xiao, Dennis J Templeton, Qingxiang Amy Sang, Keith Brew, Isa M Hussaini.   

Abstract

Previous reports showed that urokinase plasminogen activator (uPA) converts plasminogen to plasmin which then activates matrix metalloproteinases (MMPs). Here, we report that uPA directly cleaved pro-MMP-9 in a time-dependent manner at both C- and N-terminus and generated two gelatinolytic bands. uPA-activated-MMP-9 efficiently degraded fibronectin and blocked by uPA inhibitor B428 and recombinant tissue inhibitor of metalloproteinase-1 (TIMP-1). B428 inhibited basal and PMA-induced active MMP-9 in glioblastomas (GBM) U1242 cell media as well as cell invasion in vitro. A combination of MMP-9 and uPA antibodies more significantly inhibited U1242 cell invasion than uPA or MMP-9 antibody alone. Both uPA and MMP-9 were highly expressed in U1242 cell and GBM patient specimens. Furthermore, two active MMP-9 fragments with identical molecular weights to the uPA-activated MMP-9 products were detected in GBM patient specimens. These results suggest that uPA-mediated direct activation of MMP-9 may promote GBM cell invasion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355442      PMCID: PMC2562868          DOI: 10.1016/j.bbrc.2008.03.038

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

2.  Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.

Authors:  Marta Toth; Irina Chvyrkova; M Margarida Bernardo; Sonia Hernandez-Barrantes; Rafael Fridman
Journal:  Biochem Biophys Res Commun       Date:  2003-08-22       Impact factor: 3.575

3.  X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding.

Authors:  Daniela Jozic; Gleb Bourenkov; Ngee-Han Lim; Robert Visse; Hideaki Nagase; Wolfram Bode; Klaus Maskos
Journal:  J Biol Chem       Date:  2004-12-15       Impact factor: 5.157

4.  Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.

Authors:  Yun-Ge Zhao; Ai-Zhen Xiao; Robert G Newcomer; Hyun I Park; Tiebang Kang; Leland W K Chung; Mark G Swanson; Haiyen E Zhau; John Kurhanewicz; Qing-Xiang Amy Sang
Journal:  J Biol Chem       Date:  2003-02-13       Impact factor: 5.157

5.  The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.

Authors:  H E Van Wart; H Birkedal-Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 6.  Molecular mechanisms of glioma invasiveness: the role of proteases.

Authors:  Jasti S Rao
Journal:  Nat Rev Cancer       Date:  2003-07       Impact factor: 60.716

Review 7.  Cell surface association of matrix metalloproteinase-9 (gelatinase B).

Authors:  Rafael Fridman; Marta Toth; Irina Chvyrkova; Samy O Meroueh; Shahriar Mobashery
Journal:  Cancer Metastasis Rev       Date:  2003 Jun-Sep       Impact factor: 9.264

8.  Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.

Authors:  Y Ogata; J J Enghild; H Nagase
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

Review 9.  The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer.

Authors:  M J Duffy; C Duggan
Journal:  Clin Biochem       Date:  2004-07       Impact factor: 3.281

10.  Quantitative analysis of modified proteins by LC-MS/MS of peptides labeled with phenyl isocyanate.

Authors:  Daniel E Mason; Daniel C Liebler
Journal:  J Proteome Res       Date:  2003 May-Jun       Impact factor: 4.466

View more
  22 in total

1.  Urokinase-type plasminogen activator induces BV-2 microglial cell migration through activation of matrix metalloproteinase-9.

Authors:  Sun Mi Shin; Kyu Suk Cho; Min Sik Choi; Sung Hoon Lee; Seol-Heui Han; Young-Sun Kang; Hee Jin Kim; Jae Hoon Cheong; Chan Young Shin; Kwang Ho Ko
Journal:  Neurochem Res       Date:  2010-02-23       Impact factor: 3.996

2.  Multidimensional hydrogel models reveal endothelial network angiocrine signals increase glioblastoma cell number, invasion, and temozolomide resistance.

Authors:  Mai T Ngo; Elijah Karvelis; Brendan A C Harley
Journal:  Integr Biol (Camb)       Date:  2020-06-19       Impact factor: 2.192

3.  Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells.

Authors:  Satoshi Takahashi; Hisafumi Yamada-Okabe; Kenji Hamada; Shigeki Ohta; Takeshi Kawase; Kazunari Yoshida; Masahiro Toda
Journal:  J Neurooncol       Date:  2010-09-16       Impact factor: 4.130

4.  An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9.

Authors:  Yunge Zhao; Aizhen Xiao; Charles G diPierro; Joan E Carpenter; Rana Abdel-Fattah; Gerard T Redpath; Maria-Beatriz S Lopes; Isa M Hussaini
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

5.  Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation.

Authors:  Robert H Scannevin; Richard Alexander; Tara Mezzasalma Haarlander; Sharon L Burke; Monica Singer; Cuifen Huo; Yue-Mei Zhang; Diane Maguire; John Spurlino; Ingrid Deckman; Karen I Carroll; Frank Lewandowski; Eric Devine; Keli Dzordzorme; Brett Tounge; Cindy Milligan; Shariff Bayoumy; Robyn Williams; Celine Schalk-Hihi; Kristi Leonard; Paul Jackson; Matthew Todd; Lawrence C Kuo; Kenneth J Rhodes
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

6.  Prognostic value of tumor-related molecular expression in gastric carcinoma.

Authors:  Zhong-Sheng Zhao; Yuan-Yu Wang; Zai-Yuan Ye; Hou-Quan Tao
Journal:  Pathol Oncol Res       Date:  2009-03-18       Impact factor: 3.201

7.  Identification of regulatory Hck and PAI-2 proteins in the monocyte response to PEG-containing matrices.

Authors:  Sean T Zuckerman; James F Brown; Weiyuan J Kao
Journal:  Biomaterials       Date:  2009-05-14       Impact factor: 12.479

8.  Predominant role of host proteases in myocardial damage associated with infectious endocarditis induced by Enterococcus faecalis in a rat model.

Authors:  Pascal Augustin; Ghada Alsalih; Yoann Launey; Sandrine Delbosc; Liliane Louedec; Véronique Ollivier; Françoise Chau; Philippe Montravers; Xavier Duval; Jean-Baptiste Michel; Olivier Meilhac
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

9.  Urokinase plasminogen activator gene deficiency inhibits fracture cartilage remodeling.

Authors:  Nicoleta L Popa; Jon E Wergedal; K-H William Lau; Subburaman Mohan; Charles H Rundle
Journal:  J Bone Miner Metab       Date:  2013-05-23       Impact factor: 2.626

10.  Creation of an apoptin-derived peptide that interacts with SH3 domains and inhibits glioma cell migration and invasion.

Authors:  Weiwei Song; Hengyu Zhao; Zhongqi Cui; Xiaoyu Ma; Wenwen Zhang; Di Wang; Anqi Liu; Lijie Yuan
Journal:  Tumour Biol       Date:  2016-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.